Vicarious Surgical

Vicarious Surgical is focused on advancing minimally invasive surgery through robotic systems. Their R&D includes pitch motion control of surgical instruments around a virtual center, enhancing stereoscopic visualization, and implementing multi-turn rotary actuators. They are developing cartridges for tool exchange, multispectral imaging cameras, and systems with internal degrees of freedom for laparoscopic surgery. Additionally, they are working on methods for controlling robotic arms in constrained spaces, drive assemblies, and tool exchanging mechanisms. Their research also encompasses depth perception, virtual reality surgical systems, force estimation, thermal management, lens cleaning for surgical cameras, and magnetic sensing systems for robotic procedures.

Vicarious Surgical announced a 1-for-30 reverse stock split following shareholder approval. The company had cash of $84 million as of March 2024, with a cash burn of $60 million over the past year, indicating a cash runway of approximately 17 months. Additionally, Vicarious Surgical beat earnings expectations in Q1 2024.